m⁶A-modification regulated circ-CCT3 acts as the sponge of miR-378a-3p to promote hepatocellular carcinoma progression

References

• Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6. DOI:10.1038/s41572-020-00240-3
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: gLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–13. DOI:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Khan AA, Liu ZK, Xu X. Recent advances in immunotherapy for hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2021;20(6):511–520.
   PubMed Web of Science ®Google Scholar
• Singal AG, Lampertico P, Nahon P. Epidemiology and surveillance for hepatocellular carcinoma: new trends. J Hepatol. 2020;72(2):250–261.
   PubMed Web of Science ®Google Scholar
• Wang M, Yu F, Li P. Circular RNAs: characteristics, Function and Clinical Significance in Hepatocellular Carcinoma. Cancers (Basel). 2018;10(8). DOI:10.3390/cancers10080258
   Web of Science ®Google Scholar
• Meng S, Zhou H, Feng Z, et al. Epigenetics in Neurodevelopment: emerging Role of Circular RNA. Front Cell Neurosci. 2019;13:327.
   PubMed Web of Science ®Google Scholar
• Han TS, Hur K, Cho HS, et al. Epigenetic Associations between lncRNA/circRNA and miRNA in Hepatocellular Carcinoma. Cancers (Basel). 2020;12(9):2622.
   PubMed Web of Science ®Google Scholar
• Sanger HL, Klotz G, Riesner D, et al. Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proc Natl Acad Sci U S A. 1976;73(11):3852–3856.
   PubMed Web of Science ®Google Scholar
• Bach DH, Lee SK, Sood AK. Circular RNAs in Cancer. Mol Ther Nucleic Acids. 2019;16:118–129.
   PubMedGoogle Scholar
• He L, Man C, Xiang S, et al. Circular RNAs’ cap-independent translation protein and its roles in carcinomas. Mol Cancer. 2021;20(1):119.
   PubMed Web of Science ®Google Scholar
• Yu J, Xu QG, Wang ZG, et al. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma. J Hepatol. 2018;68(6):1214–1227. DOI:10.1016/j.jhep.2018.01.012
   PubMed Web of Science ®Google Scholar
• Zhang C, Ding R, Sun Y, et al. Circular RNA in tumor metastasis. Mol Ther Nucleic Acids. 2021;23:1243–1257.
   PubMedGoogle Scholar
• Lin Z, Tang X, Wan J, et al. Functions and mechanisms of circular RNAs in regulating stem cell differentiation. RNA Biol. 2021;18(12):2136–2149.
   PubMed Web of Science ®Google Scholar
• Cui C, Yang J, Li X, et al. Functions and mechanisms of circular RNAs in cancer radiotherapy and chemotherapy resistance. Mol Cancer. 2020;19(1):58.
   PubMed Web of Science ®Google Scholar
• Chen J, Yang X, Liu R, et al. Circular RNA GLIS2 promotes colorectal cancer cell motility via activation of the NF-κB pathway. Cell Death Dis. 2020;11(9):788. DOI:10.1038/s41419-020-02989-7
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Hansen TB, Venø MT, et al. Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2018;37(5):555–565.
   PubMed Web of Science ®Google Scholar
• Yu L, Gong X, Sun L, et al. The Circular RNA Cdr1as Act as an Oncogene in Hepatocellular Carcinoma through Targeting miR-7 Expression. PLoS ONE. 2016;11(7):e0158347.
   PubMed Web of Science ®Google Scholar
• Yang W, Du WW, Li X, et al. Foxo3 activity promoted by non-coding effects of circular RNA and Foxo3 pseudogene in the inhibition of tumor growth and angiogenesis. Oncogene. 2016;35(30):3919–3931.
   PubMed Web of Science ®Google Scholar
• Han D, Li J, Wang H, et al. Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression. Hepatology. 2017;66(4):1151–1164. DOI:10.1002/hep.29270
   PubMed Web of Science ®Google Scholar
• Dong Y, He D, Peng Z, et al. Circular RNAs in cancer: an emerging key player. J Hematol Oncol. 2017;10(1):2. DOI:10.1186/s13045-016-0370-2
   PubMed Web of Science ®Google Scholar
• Jiang T, Xia Y, Lv J, et al. A novel protein encoded by circMAPK1 inhibits progression of gastric cancer by suppressing activation of MAPK signaling. Mol Cancer. 2021;20(1):66. DOI:10.1186/s12943-021-01358-y
   PubMed Web of Science ®Google Scholar
• Verduci L, Strano S, Yarden Y, et al. The circRNA-microRNA code: emerging implications for cancer diagnosis and treatment. Mol Oncol. 2019;13(4):669–680.
   PubMed Web of Science ®Google Scholar
• Li W, Xu Y, Wang X, et al. circCCT3 Modulates Vascular Endothelial Growth Factor a and Wnt Signaling to Enhance Colorectal Cancer Metastasis Through Sponging miR-613. DNA Cell Biol. 2020;39(1):118–125. DOI:10.1089/dna.2019.5139
   PubMed Web of Science ®Google Scholar
• Byrne AM, Bouchier-Hayes DJ, Harmey JH. Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med. 2005;9(4):777–794.
   PubMed Web of Science ®Google Scholar
• Ceci C, Atzori MG, Lacal PM, et al. Role of VEGFs/VEGFR-1 Signaling and its Inhibition in Modulating Tumor Invasion: experimental Evidence in Different Metastatic Cancer Models. Int J Mol Sci. 2020;21(4):1388.
   PubMed Web of Science ®Google Scholar
• Zhang L, Hou C, Chen C, et al. The role of N(6)-methyladenosine (m(6)A) modification in the regulation of circRnas. Mol Cancer. 2020;19(1):105. DOI:10.1186/s12943-020-01224-3
   PubMed Web of Science ®Google Scholar
• Du A, Li S, Zhou Y, et al. M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma. Mol Cancer. 2022;21(1):109. DOI:10.1186/s12943-022-01575-z
   PubMed Web of Science ®Google Scholar
• Wang X, Lu Z, Gomez A, et al. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature. 2014;505(7481):117–120. DOI:10.1038/nature12730
   PubMed Web of Science ®Google Scholar
• Tao M, Zheng M, Xu Y, et al. CircRNAs and their regulatory roles in cancers. Mol Med. 2021;27(1):94.
   PubMed Web of Science ®Google Scholar
• Qian F, Wang J, Wang Y, et al. MiR-378a-3p as a putative biomarker for hepatocellular carcinoma diagnosis and prognosis: computational screening with experimental validation. Clin Transl Med. 2021;11(2):e307. DOI:10.1002/ctm2.307
   PubMed Web of Science ®Google Scholar
• Yamaguchi R, Yano H, Nakashima Y, et al. Expression and localization of vascular endothelial growth factor receptors in human hepatocellular carcinoma and non-HCC tissues. Oncol Rep. 2000;7(4):725–729. DOI:10.3892/or.7.4.725
   PubMed Web of Science ®Google Scholar
• Huang X, Guo H, Wang L, et al. Recent advances in crosstalk between N6-methyladenosine (m6A) modification and circular RNAs in cancer. Mol Ther Nucleic Acids. 2022;27:947–955.
   PubMedGoogle Scholar